We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
BIO One-on-One Partnering at JPM Week 2024, taking place in San Francisco, on January 8-12, 2024, unifies access to partnering for the life science industry. You can efficiently meet with biotechs, investors, in-licensors, medical device and medtech companies, and other life science leaders.
OCT Clinical is going to play an active part in this partnering event. If you want to book a partnering with us, reach out to our representative at the event, Anna Lineva, Business Development Manager, at her email address alineva@oct-clinicaltrials.com
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.